USPTO 2015–2025 USPTO PatentsView US Corporation

Howmedica Osteonics Corp.

USPTO PatentsView assignee record - 583 granted patents across 56 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

583
Total patents granted
56
CPC technology areas
18.1
Avg claims per patent
+84%
5-year filing velocity

The verdict

Howmedica holds 583 US patents across 56 technology areas, rank #788 of 50,000 tracked assignees.

#788
of 50,000 US assignees by volume
Top 1%
by Innovation Score (66.0/100)
18.1
avg claims per patent
+84%
filing velocity, last 5 yrs

Portfolio overview

Howmedica Osteonics Corp. has been granted 583 US utility patents between 2015 and 2025, placing Howmedica Osteonics Corp. at rank #788 across all assignees tracked by PlainPatent. This portfolio spans 56 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.1 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Howmedica Osteonics Corp. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Howmedica sits between North Carolina State University (585 patents, rank #784) and University Of Central Florida Research Foundation (581 patents, rank #792) - the closest US assignees by grant volume. The composite Innovation Score of 66.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 378 grants, compared with 205 in the 2015–2019 window, a +84% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Howmedica Osteonics Corp.'s 18.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 56 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Howmedica Osteonics Corp. against peers pursuing similar technology classes.

Who files at Howmedica's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Howmedica holds 583 patents at rank #788, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Howmedica

By rank, the assignees closest to #788 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Howmedica's primary technology class.

Howmedica's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

66 Top 1% higher than 99% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). Below this entry. 60–70: 1,537 US assignees (3%). This entry sits in this band. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

20406080100 20152016201720182019202020212022202320242025 69
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Howmedica Osteonics Corp. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 40 6.9%
2016 31 5.3%
2017 46 7.9%
2018 36 6.2%
2019 52 8.9%
2020 51 8.7%
2021 59 10.1%
2022 58 9.9%
2023 53 9.1%
2024 88 15.1%
2025 69 11.8%

Which technologies does Howmedica Osteonics Corp. patent most?

Top 15 of 56 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#788

Across all tracked assignees

Innovation Score

66.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Howmedica Osteonics Corp. hold?
Howmedica Osteonics Corp. holds 583 US granted patents filed between 2015 and 2025, spanning 56 technology areas.
What is Howmedica Osteonics Corp.'s Innovation Score?
Howmedica Osteonics Corp. has an Innovation Score of 66.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Howmedica Osteonics Corp. focus on?
Howmedica Osteonics Corp.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 392 patents. The company has filed patents in 56 CPC subclasses total.
Is Howmedica Osteonics Corp.'s patent filing rate increasing or decreasing?
Howmedica Osteonics Corp.'s recent filing velocity is +84% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Howmedica Osteonics Corp.'s patents?
Howmedica Osteonics Corp.'s patents average 18.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the Howmedica Osteonics Corp. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Howmedica's 583 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Howmedica ranks #788 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.